Going all in: BNP Paribas bets on Exane buyout to complete its CIB vision

In buying out its Exane equities joint venture partner, BNP Paribas reckons it can make a success of a business where few European peers have thrived. It also hopes to see a halo effect on underperforming franchises like ECM.

When Yann Gérardin was toiling away on the fringes of the dealing room at pre-merger Banque Nationale de Paris, putting together an equity derivatives desk in the late 1980s, the prospect of being able to deploy a full-service equities franchise must have seemed far away. But now, as deputy chief operating officer of BNP Paribas and head of its corporate and institutional bank, he is about to preside over a radical change that he thinks will transform how the firm transacts with its equities clients.

Thanks for your interest in Euromoney!
To unlock this article: